Groupe Athena, Inc. Welcomes New Director, Announces Intent to Apply for UK License
September 05 2013 - 9:15AM
Business Wire
Groupe Athena, Inc. (OTC Pink:GATA.PK) announced today that Dr.
Chitra Saxena has been elected to join their Board of Directors.
Dr. Saxena is a skilled expert in UK and European regulatory
requirements for prescription and non-prescription pharmaceutical
drugs. During her distinguished career, she has been associated
with several multinational companies including Reckitt Benckiser,
Slough, UK, Bayer PLC, Newbury, UK and DDSA Pharmaceuticals
Limited, Fulham, UK. She has also published 23 research papers in
various internationally reputed trade journals.
In related news, Groupe Athena, under the guidance of Dr.
Saxena, will commence the application process to obtain regulatory
approval for licenses for the sale of certain prescription drugs
within the UK and later in the European Union. The process is
likely to be completed within 18-24 months. This will include plant
approvals, pilot manufacturing and licensing.
Groupe Athena Chairman, D. Purohit stated, “We are very
privileged to have Dr. Saxena join our board of Directors, and her
knowledge of the regulatory and licensing processes within the UK
and EU will prove invaluable as we transition to the manufacturing
and marketing side of the pharmaceutical industry.”
The Indian pharmaceutical industry was estimated to be over $21
Billion in 2010 and is expected to experience double-digit annual
growth through the end of the decade. GATA has emerged as a vital
component of this growth by its ability to help Indian
manufacturers get their products approved by the FDA for sales in
the US.
For more information on Groupe Athena, Inc. please go to
www.otcmarkets.com/stock/GATA/quote or visit our corporate website
at www.groupeathena.com.
About Groupe Athena, Inc.
Groupe Athena Inc. was incorporated in June 2008 and began
operations on July 1 of that year. The company is a research and
testing organization and helps various pharmaceutical and medical
products and devices companies in India and Southeast Asia to get
regulatory approvals and facilitate exports of their products to
the United States. The Company accomplishes this by assisting
clients from concept through development, providing consultation on
regulatory requirements, filings and processes.
The company has a research and marketing facility in India that
currently employs 17 consultants and marketing personnel and is
working towards aggressively expanding its presence in the Indian
pharmaceutical industry. The Company’s web address is
www.groupeathena.com
For more information contact:Paul CornellCorporate Shareholder
RelationsCornellpaul6@gmail.com
Safe Harbor StatementCertain statements set forth in this
press release constitute "forward-looking statements.”
Forward-looking statements include, without limitation, any
statement that may predict, forecast, indicate, or imply future
results, performance or achievements, and may contain the words
"estimate", "project", "intend", "forecast", "anticipate", "plan",
"planning", "expect", "believe", "will likely", "should", "could",
"would", "may" or words or expressions of similar meaning. Such
statements are not guarantees of future performance and are subject
to risks and uncertainties that could cause the company's actual
results and financial position to differ materially from those
included within the forward-looking statements. Forward-looking
statements involve risks and uncertainties, including those
relating to the Company's ability to grow its business. Actual
results may differ materially from the results predicted and
reported results should not be considered as an indication of
future performance. The potential risks and uncertainties include,
among others, the Company's limited operating history, the limited
financial resources, domestic or global economic conditions --
activities of competitors and the presence of new or additional
competition and conditions of equity markets.
Groupe Athena Inc.Paul Cornell, 1-877-647-6876Corporate
Shareholder RelationsCornellpaul6@gmail.com